Drug Shortage Report for RECOMBIVAX HB

Last updated on 2020-02-13 History
Report ID 43284
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5MCG/0.5ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-21
Actual start date 2018-03-19
Estimated end date 2020-08-17
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments Recombivax HB (Pediatric): Anticipated end date of the shortage mid-Aug 2020 (tbc).
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-02-13 French Compare
v14 2020-02-13 English Compare
v13 2020-02-10 French Compare
v12 2020-02-10 English Compare
v11 2020-01-06 French Compare
v10 2020-01-06 English Compare
v9 2019-07-04 French Compare
v8 2019-07-04 English Compare
v7 2019-04-01 English Compare
v6 2018-12-11 English Compare
v5 2018-03-20 English Compare
v4 2018-03-19 French Compare
v3 2018-03-19 English Compare
v2 2018-03-19 English Compare
v1 2018-03-19 English Compare